• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用癌症基因组图谱评估胰腺腺癌中K-ras和p53的表达

Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.

作者信息

Lu Liming, Zeng Jingchun

机构信息

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.

The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

出版信息

PLoS One. 2017 Jul 25;12(7):e0181532. doi: 10.1371/journal.pone.0181532. eCollection 2017.

DOI:10.1371/journal.pone.0181532
PMID:28742845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5526503/
Abstract

Genetic alterations in K-ras and p53 are thought to be critical in pancreatic cancer development and progression. However, K-ras and p53 expression in pancreatic adenocarcinoma have not been systematically examined in The Cancer Genome Atlas (TCGA) Data Portal. Information regarding K-ras and p53 alterations, mRNA expression data, and protein/protein phosphorylation abundance was retrieved from The Cancer Genome Atlas (TCGA) databases, and analyses were performed by the cBioPortal for Cancer Genomics. The mutual exclusivity analysis showed that events in K-ras and p53 were likely to co-occur in pancreatic adenocarcinoma (Log odds ratio = 1.599, P = 0.006). The graphical summary of the mutations showed that there were hotspots for protein activation. In the network analysis, no solid association between K-ras and p53 was observed in pancreatic adenocarcinoma. In the survival analysis, neither K-ras nor p53 were associated with both survival events. As in the data mining study in the TCGA databases, our study provides a new perspective to understand the genetic features of K-ras and p53 in pancreatic adenocarcinoma.

摘要

K-ras和p53基因的改变被认为在胰腺癌的发生和发展中起着关键作用。然而,癌症基因组图谱(TCGA)数据门户尚未对胰腺腺癌中K-ras和p53的表达进行系统研究。从癌症基因组图谱(TCGA)数据库中检索了有关K-ras和p53改变、mRNA表达数据以及蛋白质/蛋白质磷酸化丰度的信息,并通过癌症基因组学cBioPortal进行了分析。互斥性分析表明,K-ras和p53事件在胰腺腺癌中可能同时发生(对数优势比=1.599,P=0.006)。突变的图形总结显示存在蛋白质激活热点。在网络分析中,未观察到胰腺腺癌中K-ras和p53之间有可靠的关联。在生存分析中,K-ras和p53均与生存事件无关。与TCGA数据库中的数据挖掘研究一样,我们的研究为理解胰腺腺癌中K-ras和p53的遗传特征提供了新的视角。

相似文献

1
Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.利用癌症基因组图谱评估胰腺腺癌中K-ras和p53的表达
PLoS One. 2017 Jul 25;12(7):e0181532. doi: 10.1371/journal.pone.0181532. eCollection 2017.
2
Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.胰腺导管腺癌中 K-ras、p53、c-erbB-2 和 DPC4 的基因改变及其与患者生存的相关性。
Pancreas. 2013 Mar;42(2):216-22. doi: 10.1097/MPA.0b013e31825b6ab0.
3
Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.胰腺腺癌中K-ras突变与p53畸变联合存在的患病率及临床意义
Int J Pancreatol. 1997 Apr;21(2):127-43. doi: 10.1007/BF02822384.
4
Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas.胰腺导管内肿瘤和浸润性导管肿瘤基因改变的免疫组织化学研究
Hepatogastroenterology. 2001 May-Jun;48(39):879-83.
5
Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.K-ras突变与慢性胰腺炎和胰腺腺癌中p21WAF1/CIP1及p53表达的关系
Neoplasma. 2003;50(5):319-25.
6
Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.胰腺癌家族癌症病史与p53、p21WAF-1、HER-2/neu表达及K-ras突变的关系
Int J Pancreatol. 1997 Jun;21(3):225-34. doi: 10.1007/BF02821608.
7
Patterns of genetic alterations in pancreatic cancer: a pooled analysis.胰腺癌的基因改变模式:一项汇总分析。
Environ Mol Mutagen. 1999;33(2):111-22. doi: 10.1002/(sici)1098-2280(1999)33:2<111::aid-em3>3.0.co;2-f.
8
Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.大鼠X射线诱导肺肿瘤中K-ras和p53信号通路的分析
Radiat Res. 1996 Apr;145(4):449-56.
9
Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.源自细胞系和原发性肿瘤且具有不同转移活性的胰腺腺癌原位移植模型。
Pancreas. 2004 Oct;29(3):193-203. doi: 10.1097/00006676-200410000-00004.
10
K-ras and p53 alterations in genomic DNA and transcripts of human pancreatic adenocarcinoma cell lines.人胰腺腺癌细胞系基因组DNA和转录本中的K-ras和p53改变
Jpn J Cancer Res. 1994 Oct;85(10):1005-14. doi: 10.1111/j.1349-7006.1994.tb02898.x.

引用本文的文献

1
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins.突变型 p53 与 p62/SQSTM1 之间的串扰通过促进细胞黏附蛋白的降解增强癌细胞迁移。
Proc Natl Acad Sci U S A. 2022 Apr 26;119(17):e2119644119. doi: 10.1073/pnas.2119644119. Epub 2022 Apr 19.
2
Gossypol Induces Apoptosis of Human Pancreatic Cancer Cells via CHOP/Endoplasmic Reticulum Stress Signaling Pathway.棉酚通过 CHOP/内质网应激信号通路诱导人胰腺癌细胞凋亡。
J Microbiol Biotechnol. 2022 May 28;32(5):645-656. doi: 10.4014/jmb.2110.10019.
3
Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers.

本文引用的文献

1
Correlation Between RAB27B and p53 Expression and Overall Survival in Pancreatic Cancer.RAB27B与p53表达及胰腺癌总生存期的相关性
Pancreas. 2016 Feb;45(2):204-10. doi: 10.1097/MPA.0000000000000453.
2
Predictive biomarkers in precision medicine and drug development against lung cancer.精准医学和肺癌药物研发中的预测性生物标志物。
Chin J Cancer. 2015 Jul 2;34(7):295-309. doi: 10.1186/s40880-015-0028-4.
3
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
血液和实体癌中Ras/丝裂原活化蛋白激酶信号传导研究及靶向治疗进展
Cancers (Basel). 2021 Oct 10;13(20):5059. doi: 10.3390/cancers13205059.
4
Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma.Ral GTP 酶激活蛋白调节胰腺导管腺癌的恶性程度。
Cancer Sci. 2021 Aug;112(8):3064-3073. doi: 10.1111/cas.14970. Epub 2021 Jun 15.
5
Chelidonine Induces Apoptosis via GADD45a-p53 Regulation in Human Pancreatic Cancer Cells.白屈菜堿通过 GADD45a-p53 调控诱导人胰腺癌细胞凋亡。
Integr Cancer Ther. 2021 Jan-Dec;20:15347354211006191. doi: 10.1177/15347354211006191.
6
Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion.胰腺癌诱导免疫逃逸的分子机制及潜在治疗逆转
Cancers (Basel). 2020 Jul 11;12(7):1872. doi: 10.3390/cancers12071872.
7
Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG).在一组接受基于白蛋白结合型紫杉醇化疗或靶向表皮生长因子受体(EGFR)轴药物治疗的患者中,通过靶向新一代测序对胰腺癌进行基因图谱分析:希腊合作肿瘤学组(HeCOG)的一项回顾性分析
ESMO Open. 2019 Sep 18;4(5):e000525. doi: 10.1136/esmoopen-2019-000525. eCollection 2019.
8
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas.胆道和胰腺肿瘤前病变和肿瘤之间的共同特征。
World J Gastroenterol. 2019 Aug 21;25(31):4343-4359. doi: 10.3748/wjg.v25.i31.4343.
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
4
High levels of cell-free circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis and poor survival.胰腺癌中高水平的游离循环核酸与血管包绕、转移及不良生存相关。
Cancer Invest. 2015 Mar;33(3):78-85. doi: 10.3109/07357907.2014.1001894. Epub 2015 Feb 3.
5
Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer.结合致癌性K-RAS/Ki67/HIF-1α通路中的临床病理预测指标和分子生物标志物以预测可切除胰腺癌的生存率。
Br J Cancer. 2015 Feb 3;112(3):514-22. doi: 10.1038/bjc.2014.659. Epub 2015 Jan 13.
6
Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma.可切除性胰腺导管腺癌患者中与胰腺癌生存相关的蛋白质。
Lab Invest. 2015 Jan;95(1):43-55. doi: 10.1038/labinvest.2014.128. Epub 2014 Oct 27.
7
Identification of dysregulated pathways associated with pancreatic cancer by survival analysis.
Mol Med Rep. 2015 Jan;11(1):277-82. doi: 10.3892/mmr.2014.2693. Epub 2014 Oct 17.
8
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.pERK、pAKT和p53作为厄洛替尼治疗的晚期胰腺癌患者的组织生物标志物:来自AIO-PK0104的转化亚组分析
BMC Cancer. 2014 Aug 28;14:624. doi: 10.1186/1471-2407-14-624.
9
Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.K-ras和p53在突尼斯人群队列结直肠癌致癌过程中的作用
Tumour Biol. 2014 Jul;35(7):7163-75. doi: 10.1007/s13277-014-1874-4. Epub 2014 Apr 25.
10
The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.可切除胰腺癌中Gli1、MDM2 和 p53 表达的临床病理意义及其关系。
Histopathology. 2014 Mar;64(4):523-35. doi: 10.1111/his.12273. Epub 2013 Dec 2.